Drugmakers raise prices on hundreds of medicines

Pharmaceutical companies are raising the price of hundreds of drugs, although many companies’ increases are relatively modest this year, amid growing public and political pressure on the industry over prices. Yet a few are particularly high, including on some generics.

Pharmaceutical companies are raising the price of hundreds of drugs, although many companies’ increases are relatively modest this year, amid growing public and political pressure on the industry over prices. Yet a few are particularly high, including on some generics. Overall, price increases, including recently restored price increases from Pfizer, continue to exceed inflation. Allergan has set the pace with increases of nearly 10% on more than two dozen products, according to a new analysis. More than three dozen drugmakers raised the prices on hundreds of medicines in the United States on Tuesday, according to the analysis from Rx Savings Solutions. The average increase was 6.3%, including increases on different doses for the same drug. Among generic drugmakers with the largest increases, Hikma Pharmaceuticals raised the price of morphine by 10%, ketamine by 20% and enalaprilat by 30%. Other drugmakers that raised their prices generally issued more-modest increases. GlaxoSmithKline confirmed it raised the prices on 36 drugs, although none exceeded 3%.